Literature DB >> 10993894

The orthologous human and murine semaphorin 6A-1 proteins (SEMA6A-1/Sema6A-1) bind to the enabled/vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel carboxyl-terminal zyxin-like domain.

A Klostermann1, B Lutz, F Gertler, C Behl.   

Abstract

Neuronal development and apoptosis critically depend on the transformation of extracellular signals to intracellular actions resulting in cytoskeletal rearrangements. Ena/VASP (enabled/vasodilator-stimulated phosphoprotein) proteins play an important role in actin and filament dynamics, whereas members of the semaphorin protein family are guidance signals in embryo- and organogenesis. Here, we report the identification of two novel transmembranous human and murine semaphorins, (HSA)SEMA6A-1 and (MMU)Sema6A-1. These semaphorin 6 variants directly link the Ena/VASP and the semaphorin protein family, since SEMA6A-1/Sema6A-1 is capable of a selective binding to the protein EVL (Ena/VASP-like protein). EVL is the third member of the Ena/VASP family of proteins that was identified sharing the same structural features as Mena (mammalian enabled) and VASP, although its functionality seems to be different from that of the other members. Here we demonstrate that SEMA6A-1/Sema6A-1 is colocalized with EVL via its zyxin-like carboxyl-terminal domain that contains a modified binding motif, which further stresses the existence of functional differences between EVL and Mena/VASP. In addition these findings suggest a completely new role for transmembranous semaphorins such as SEMA6A-1/Sema6A-1 in retrograde signaling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993894     DOI: 10.1074/jbc.M006316200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Semaphorin 6C expression in innervated and denervated skeletal muscle.

Authors:  Anna Svensson; Rolf Libelius; Sven Tågerud
Journal:  J Mol Histol       Date:  2007-06-29       Impact factor: 2.611

2.  Genetic Predictors of Susceptibility to Dermatophytoses.

Authors:  Susan M Abdel-Rahman
Journal:  Mycopathologia       Date:  2016-08-08       Impact factor: 2.574

3.  Genetic predictors of susceptibility to cutaneous fungal infections: a pilot genome wide association study to refine a candidate gene search.

Authors:  Susan M Abdel-Rahman; Barry L Preuett
Journal:  J Dermatol Sci       Date:  2012-05-27       Impact factor: 4.563

4.  Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.

Authors:  Heather M Scobie; G Jonah A Rainey; Kenneth A Bradley; John A T Young
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

Review 5.  The role of the semaphorins in cancer.

Authors:  Gera Neufeld; Yelena Mumblat; Tatyana Smolkin; Shira Toledano; Inbal Nir-Zvi; Keren Ziv; Ofra Kessler
Journal:  Cell Adh Migr       Date:  2016-08-17       Impact factor: 3.405

6.  PKC induces release of a functional ectodomain of the guidance cue semaphorin6A.

Authors:  Riley M St Clair; Caroline M Dumas; Kori S Williams; Matthew T Goldstein; Elizabeth A Stant; Alicia M Ebert; Bryan A Ballif
Journal:  FEBS Lett       Date:  2019-08-16       Impact factor: 4.124

7.  Biomarkers of human gastrointestinal tract regions.

Authors:  Elena Maria Comelli; Sofiane Lariani; Marie-Camille Zwahlen; Grigorios Fotopoulos; James Anthony Holzwarth; Christine Cherbut; Gian Dorta; Irène Corthésy-Theulaz; Martin Grigorov
Journal:  Mamm Genome       Date:  2009-08-27       Impact factor: 2.957

8.  Immediate early gene X-1 interacts with proteins that modulate apoptosis.

Authors:  Rajiv Kumar; Ward Lutz; Elena Frank; Hee-Jeong Im
Journal:  Biochem Biophys Res Commun       Date:  2004-10-29       Impact factor: 3.575

Review 9.  Semaphorins and their receptors in lung cancer.

Authors:  Vincent A Potiron; Joëlle Roche; Harry A Drabkin
Journal:  Cancer Lett       Date:  2008-07-14       Impact factor: 8.679

10.  Semaphorin 6A regulates angiogenesis by modulating VEGF signaling.

Authors:  Marta Segarra; Hidetaka Ohnuki; Dragan Maric; Ombretta Salvucci; Xu Hou; Anil Kumar; Xuri Li; Giovanna Tosato
Journal:  Blood       Date:  2012-09-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.